newsimage

Anthony Vocat

Clinical Microbiologist, CHUV

MSc in Life Science, Medical Microbiology and Parasitology, in collaboration between Novartis and the University of Neuchâtel (magna cum laude).

Anthony has been working as a microbiologist for eight years and used multidisciplinary techniques to fight against infectious diseases with global impacts, such as tuberculosis and leprosy.

With very strong experience of handling dangerous microorganisms (bacteria, fungus and virus), he is licensed in class 1, 2 and 3 biosafety level laboratories. Study director of several preclinical and clinical projects (phase I and II), he was particularly involved in the discovery and development of a new antituberculosis drug called “Macozinone”.

Active participant of multiple European consortium of infectious diseases, he successfully generated data, wrote reports and brilliantly presented and discussed data in front of a massive audience.

Anthony is passionate about sports and plays football and floorball in official teams. For a touch of adrenaline and freedom, he likes to escape on his motorcycle.

curves

Other team members

team pattern
member thumbnail
Dr. Danuta Cichocka
CEO, Co-Founder
team pattern
member thumbnail
Dr. Amanda Luraschi
Clinical Microbiologist
team pattern
member thumbnail
Dr. Eric Delarze
Clinical Microbiologist
team pattern
member thumbnail
Christèle Aubry
Clinical Microbiologist, PhD at CHUV
team pattern
member thumbnail
Dr. hab. Grzegorz Jóźwiak
Data scientist
team pattern
member thumbnail
Dr. Grzegorz Wielgoszewski
Senior Engineer
team pattern
member thumbnail
Michał Świątkowski
Senior Engineer
team pattern
member thumbnail
Roxana Buga
Engineering Assistant
team pattern
member thumbnail
Derek Brandt
Board Member
team pattern
member thumbnail
Dieter Kraft
Board Member
team pattern
member thumbnail
Prof. Gilbert Greub
Scientific Advisory Board Member
team pattern
member thumbnail
Prof. Giovanni Dietler
Inventor, Co-Founder
team pattern
member thumbnail
Dr. Sandor Kasas
Inventor, Co-Founder